Storia della carriera di Andrea Grant
Precedenti posizioni note di Andrea Grant
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Direttore/Membro del Consiglio | 16/11/2012 | 01/04/2014 |
| Amministratore Delegato | 28/12/2011 | 01/04/2014 | |
| Contatto Relazioni con gli Investitori | 28/12/2011 | 01/04/2014 | |
| Public Communications Contact | 28/12/2011 | 01/04/2014 | |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Corporate Officer/Principal | - | 02/05/2008 |
Diatranz Otsuka Ltd.
 Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Amministratore Delegato | 01/04/2014 | - |
Formazione di Andrea Grant
| University of Cambridge | Doctorate Degree |
Statistiche
Distribuzione geografica
| Nuova-Zelanda | 3 |
| Belgio | 2 |
| Regno Unito | 2 |
Posizioni
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Galapagos Genomics NV
Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery. Galapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. | Health Technology |
Diatranz Otsuka Ltd.
Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand. | Health Technology |
- Borsa valori
- Insiders
- Andrea Grant
- Esperienza
